On episode #31 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 6/8 – 6/20/23.

Hosts: Daniel Griffin and Sara Dong

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of Puscast!

Links for this episode

• Relative effectiveness of the cell-based quadrivalent influenza vaccine in preventing cardiorespiratory hospitalizations (OFID)
• Evaluation of Oseltamivir used to prevent hospitalization in outpatients with influenza (JAMA)
• Pan-ebolavirus monoclonal antibody cocktail provides protection against Ebola and Sudan viruses (JID)
• Inappropriate antibiotic prescribing and its determinants among outpatient children in low-and middle-income countries (PLOS)
• IDSA 2023 Guidance on the treatment of antimicrobial resistant gram-negative infections (IDSA)
• Evaluating antimicrobial duration for gram-negative bacteremia in patients with neutropenia (TID)
• Antibiotic myths for the ID clinician (CID)
• Dalbavancin for the treatment of acute bacterial skin and skin structure infection in patients with obesity or Diabetes (OFID)
• Global differences in the management of S. aureus bacteremia (CID)
• Clinical risk Scores to Predict Trimethoprim-Sulfamethoxazole, Fluoroquinolone, Nitrofurantoin, and Cephalosporin non-susceptibility among outpatient episodes of complicated UTI among adults (OFID)
• Continuous vs intermittent meropenem administration in critically ill patients with sepsis (JAMA)
• Current pyuria cutoffs promote inappropriate UTI diagnosis in older women (CID)
• Paenibacillus infection as a novel cause of sepsis in term neonates with high risk of sequelae in Uganda (CID)
• Antimicrobial for 7 or 14 Days for febrile urinary tract infection in men (CID)
• Candida auris‒associated hospitalizations (EID)
• Fatal invasive mold infections after transplantation of organs recovered from drowned donors (EID)

Music is by Ronald Jenkees